Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan
· Delayed Price · Currency is TWD 33.25
-0.25 (-0.75%)
Jun 27, 2025, 1:43 PM CST
Taiwan Bio Therapeutics Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.99 billion as of June 27, 2025. Its market cap has increased by 54.04% in one year.
Market Cap
2.99B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
33.25
Market Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.99B, an increase of 54.65%. That is a compound annual growth rate of 14.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 2.81B | -20.65% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 207.06B |
| PharmaEssentia | 182.30B |
| Bora Pharmaceuticals Co., LTD. | 84.51B |
| Lotus Pharmaceutical | 57.58B |
| Oneness Biotech | 30.80B |
| Polaris Group | 30.51B |
| Center Laboratories | 27.10B |
| Lumosa Therapeutics | 25.58B |